# Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

> **NCT01578317** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 43 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** H5N1 vaccine plus AS03 adjuvant
- **BIOLOGICAL:** H5N1 vaccine without adjuvant

## Key facts

- **NCT ID:** NCT01578317
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-20
- **Primary completion:** 2016-01-31
- **Final completion:** 2016-01-31
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578317, "Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01578317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*